Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online calls and deadlines has predictably returned. But what can you do? The world, such as it is, keeps spinning. So time to give it a nudge with a delightful cup of stimulation. Our choice today is gingerbread spice for those who track this sort of thing. Still another cup will be hoisted, however, to note this marks 15 years since Pharmalot got under way. Nothing like longevity. Meanwhile, here are a few tidbits to help you on your journey. Hope all goes well, and do stay in touch. We enjoy the postcards and telegrams. …

Unilever (UL) has signaled it will continue pursuing a blockbuster deal to buy the GlaxoSmithKline (GSK) consumer health care unit, the BBC says. The drug maker already rejected an unsolicited offer made late last year that valued the business at about $68.4 billion, but Glaxo has said it wants to offload the unit. Unilever maintains an acquisition would be a “strong strategic fit” and wants a bigger slice of the health and hygiene sectors. The GSK unit owns brands such as Sensodyne toothpaste, the Advil painkiller, and Centrum vitamins. Unilever has not said if it will sweeten its offer, but has reportedly held talks with its banks about additional financing for a higher bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment